Mazabraud Yann: insider trades.
Mazabraud Yann reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($6.6M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Mazabraud Yann
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Officer · EVP, Head of International | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 14,568 | $115.43 | 91,182 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 18,208 | $116.49 | 72,974 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 17,319 | $117.47 | 55,655 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 1,000 | $112.86 | 109,355 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 2,300 | $111.8 | 110,355 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | M | 46,625 | $6.8 | 112,655 | Form 4 |
| 2026-08-12 | Rhythm Pharmaceuticals, Inc. | S | 3,605 | $114.7 | 105,750 | Form 4 |
Questions
What stock did Mazabraud Yann buy or sell?
Mazabraud Yann reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($6.6M), across 1 company.
Is Mazabraud Yann the same person as other filers with this name?
This page covers SEC CIK 1774702 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mazabraud-yann-1774702.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.